PODCAST: 12/22/2022

(December 12, 2022) | By Life Science Success.

In this episode of Life Science Success, my guest is Ross Youngs. Ross is the CEO and Founder of Biosortia Pharmaceutical. Ross is working to Provide previously unobtainable drug-like small molecules directly from microbiomes.

Listen Now

Share:

0 Comments

Industry News

A subset of viruses thrives following microbial resuscitation during rewetting of a seasonally dry California grassland soil September 20, 2023
Recovery of the gut microbiome following enteric infection and persistence of antimicrobial resistance genes in specific microbial hosts September 19, 2023
Ecophysiology and interactions of a taurine-respiring bacterium in the mouse gut September 18, 2023
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia September 16, 2023
A mucin-foraging bacterium modulates breakdown of oral tolerance September 15, 2023
Growth phase estimation for abundant bacterial populations sampled longitudinally from human stool metagenomes September 14, 2023
Request for public discussion and ballot to amend SeqCode rules on priority of Candidatus names and correction of typographic and orthographic errors September 14, 2023
Pioneering microbiome engineering September 12, 2023
The oral microbiome: diversity, biogeography and human health September 12, 2023
Oxytetracycline and heavy metals promote the migration of resistance genes in the intestinal microbiome by plasmid transfer September 12, 2023

Biosortia Microbiomics provides small molecules, datasets, & other opportunities from our deep access to the hidden small molecules in microbiomes.

Quick Link

Products & Services
Blog
Contact